Why Precision Oncology Is Not Very Precise (and Why This Should Not Surprise Us)
Author:
Publisher
Springer International Publishing
Link
https://link.springer.com/content/pdf/10.1007/978-3-030-74804-3_1
Reference50 articles.
1. Asad, Juhi, Allyson F. Jacobson, Alison Estabrook, Sharon Rosenbaum Smith, Susan K. Boolbol, Sheldon M. Feldman, Michael P. Osborne, Kwadwo Boachie-Adjei, Wendy Twardzik, and Paul I. Tartter. 2008. Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer? The American Journal of Surgery 196 (4): 527–529.
2. Bissell, Mina, and William C. Hines. 2011. Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Medicine 17 (3): 320.
3. Carlisle, B.G., T. Zheng, and J. Kimmelman. 2020. Imatinib and the long tail of targeted drug development. Nature Reviews Clinical Oncology 17 (1): 1–3. https://doi.org/10.1038/s41571-019-0287-0.
4. Chin-Yee, B., B. Sadikovic, and I.H. Chin-Yee. 2019. Genomic data in prognostic models — What is lost in translation? The case of deletion 17p and mutant TP53 in chronic lymphocytic leukemia. British Journal of Hematology. https://doi.org/10.1111/bjh.15827.
5. Collins, Francis S., and Harold Varmus. 2015. A new initiative on precision medicine. New England Journal of Medicine 372 (9): 793–795.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Minimal residual disease: premises before promises;Biology & Philosophy;2024-08
2. Diagnostic staging and stratification in psychiatry and oncology: clarifying their conceptual, epistemological and ethical implications;Medicine, Health Care and Philosophy;2024-05-17
3. The roots of (in)equity in precision medicine: gaps in the discourse;Personalized Medicine;2024-01
4. Precision medicine and the problem of structural injustice;Medicine, Health Care and Philosophy;2023-05-25
5. Which Integration for Health? Comparing Integrative Approaches for Epidemiology;Integrative Approaches in Environmental Health and Exposome Research;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3